These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 35655814)

  • 1. Role of
    Luo ZH; Lu PX; Qi WL; Liao FX; Jin AF; Zen QY
    Quant Imaging Med Surg; 2022 Jun; 12(6):3351-3363. PubMed ID: 35655814
    [TBL] [Abstract][Full Text] [Related]  

  • 2.
    Obert J; Vercellino L; Van Der Gucht A; de Margerie-Mellon C; Bugnet E; Chevret S; Lorillon G; Tazi A
    Eur J Nucl Med Mol Imaging; 2017 Apr; 44(4):598-610. PubMed ID: 27645693
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The value of 18F-FDG PET/CT in Langerhans cell histiocytosis.
    An R; Ma X; Wang Y
    Ann Nucl Med; 2024 Mar; 38(3):238-245. PubMed ID: 38217750
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of
    Albano D; Bosio G; Giubbini R; Bertagna F
    Jpn J Radiol; 2017 Oct; 35(10):574-583. PubMed ID: 28748503
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The usefulness of F-18 fluorodeoxyglucose positron emission tomography/computed tomography in patients with Langerhans cell histiocytosis.
    Lee HJ; Ahn BC; Lee SW; Lee J
    Ann Nucl Med; 2012 Nov; 26(9):730-7. PubMed ID: 22797842
    [TBL] [Abstract][Full Text] [Related]  

  • 6. FDG PET-CT in pediatric Langerhans cell histiocytosis.
    Jessop S; Crudgington D; London K; Kellie S; Howman-Giles R
    Pediatr Blood Cancer; 2020 Jan; 67(1):e28034. PubMed ID: 31599488
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Application of
    Liao F; Luo Z; Huang Z; Xu R; Qi W; Shao M; Lei P; Fan B
    Contrast Media Mol Imaging; 2022; 2022():8385332. PubMed ID: 36051931
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discrepancies between F-18-FDG PET/CT findings and conventional imaging in Langerhans cell histiocytosis.
    Ferrell J; Sharp S; Kumar A; Jordan M; Picarsic J; Nelson A
    Pediatr Blood Cancer; 2021 Apr; 68(4):e28891. PubMed ID: 33442960
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preliminary study on the evaluation of Langerhans cell histiocytosis using F-18-fluoro-deoxy-glucose PET/CT.
    Zhou W; Wu H; Han Y; Wang S; Dong Y; Wang Q
    Chin Med J (Engl); 2014; 127(13):2458-62. PubMed ID: 24985583
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The added value of skeletal surveys in the initial evaluation of children diagnosed with Langerhans cell histiocytosis in the era of staging
    Rameh V; Voss S; Bedoya MA; Beaulieu D; Zhang D; Degar BA; Tsai A
    Pediatr Blood Cancer; 2023 Jan; 70(1):e30057. PubMed ID: 36266951
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Muscle Infiltrative Adult Multisystem Langerhans Cell Histiocytosis Detected on Fluorodeoxyglucose Positron Emission Tomography/ Computed Tomography - A Rare Case.
    Rayamajhi SJ; Shahi RR; Maharjan S; Sharma S; Sudhir Suman KC
    Indian J Nucl Med; 2020; 35(4):342-344. PubMed ID: 33642763
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 18F-fluorodeoxyglucose positron emission tomography/computed tomography for primary thyroid langerhans histiocytosis: A case report and literature review.
    Long Q; Shaoyan W; Hui W
    Indian J Nucl Med; 2015; 30(4):328-30. PubMed ID: 26430317
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    Garcia JR; Riera E; Bassa P; Mourelo S; Soler M
    Rev Esp Med Nucl Imagen Mol; 2017; 36(5):325-328. PubMed ID: 28262495
    [TBL] [Abstract][Full Text] [Related]  

  • 14. More advantages in detecting bone and soft tissue metastases from prostate cancer using
    Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
    Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comprehensive considerations for dermatologists: the application of FDG-PET in evaluating cutaneous lesions in pediatric Langerhans cell histiocytosis.
    Talasila S; Teichner EM; Subtirelu RC; Talasila NCP; Mannam S; Werner T; Alavi A; Revheim ME
    Front Med (Lausanne); 2024; 11():1378638. PubMed ID: 39071084
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The baseline metabolism parameters of
    Lu X; Wei A; Wang G; Du J; Feng L; Ou W; Wang T; Wang W; Li J; Zhang M; Zhang R; Yang J
    Quant Imaging Med Surg; 2023 Sep; 13(9):5934-5944. PubMed ID: 37711802
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of FDG-PET scans to conventional radiography and bone scans in management of Langerhans cell histiocytosis.
    Phillips M; Allen C; Gerson P; McClain K
    Pediatr Blood Cancer; 2009 Jan; 52(1):97-101. PubMed ID: 18951435
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    Niu J; Liang J; Feng Q; Wang M; Wang L; Ge X; Wang X; Ding Z
    Int J Gen Med; 2021; 14():6251-6259. PubMed ID: 34629891
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The utility of
    Kitajima K; Kawanaka Y; Komoto H; Minami T; Yokoi T; Kuribayashi K; Kijima T; Nakamura A; Hashimoto M; Kondo N; Hasegawa S; Yamakado K
    Hell J Nucl Med; 2021; 24(3):186-198. PubMed ID: 34901959
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adult Presentation of Cutaneous Langerhans Cell Histiocytosis: 18 F-FDG PET/CT Detection of Systemic Disease.
    Robinson E; Nawwar A; Searle J; Lyburn I
    Clin Nucl Med; 2024 Apr; 49(4):333-334. PubMed ID: 38377389
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.